The Ontario, Canada-based university spent 15 years creating the device. The prototype consists of a small sensor in an adjustable box that sits under an opening in a padded examination table. The device’s sensor then emits microwaves that scan the patient and allows the AI software to compare the breast tissue composition.
The system is able to detect anomalies less than one centimeter in diameter. A negative result could quickly rule out cancer, and a positive result would trigger a referral for more extensive testing using mammography or MRI technology.
“If women were screened regularly with this, potential problems would be caught much sooner – in the early stages of cancer,” said Omar Ramahi, professor of electrical and computer engineering at Waterloo, according to the news release. “Our system can complement existing technology, reserving much more expensive options for when they’re really needed.”
University researchers have applied for a patent and started a company, Wave Intelligence, to commercialize the system. They hope to begin patient trials in the next six months.
More articles on artificial intelligence:
How AI will transform healthcare: KPMG report
Mayo Clinic AI enables EKGs to screen for hypertrophic cardiomyopathy
Sutter Health deploys AI platform to catch imaging discrepancies
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.